Bristol-Myers Squibb Company announced that due to the ongoing COVID-19 pandemic, it will reschedule its planned April 2, 2020 Investor Day for a later date.
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced that due to the ongoing COVID-19 pandemic, it will reschedule its planned April 2, 2020 Investor Day for a later date. The company will continue to assess the situation and follow guidance from local and global health authorities to determine the new date.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200323005105/en/
Bristol-Myers Squibb
Media:
media@bms.com
609-252-3345
Investors:
Tim Power, 609-252-7509, timothy.power@bms.com
Nina Goworek, 908-673-9711, ngoworek@bms.com
Source: Bristol-Myers Squibb Company
View this news release online at:
http://www.businesswire.com/news/home/20200323005105/en
